Understanding Hemophilia’s Impact
Hemophilia is a rare genetic bleeding disorder that affects over 30,000 people in the U.S. and requires a lifetime of intensive management and individualized care strategies by both the health care team and patient. Despite significant advancements in treatment—allowing most employees with hemophilia to lead full, active professional lives—the condition remains complex, costly, and often misunderstood within the employer community.
It is an important driver of employer health care costs, ranking among the top 20 highest-cost claims conditions. Total annual health care costs can be up to 25 times more for a person living with hemophilia compared to members who don’t live with this condition. The annual cost of factor therapy for a person with severe hemophilia is roughly $300,000 with total medical costs often far exceeding that amount.
Factor replacement therapy is the primary treatment for hemophilia to replace or bypass missing blood proteins. It enables proper blood clotting, either preventing bleeds (prophylaxis) or stopping active bleeds (on demand). The recommended frequency of administration varies between products.
The financial burden is only part of the challenge. Hemophilia can cause recurrent joint bleeds that lead to chronic pain, reduced mobility, and long-term musculoskeletal damage. These complications often require time away from work for treatment, recovery, medical appointments, or emergency care. Even when at work, individuals may experience a lack of concentration, fear and anxiety, fatigue, and limited stamina, affecting their ability to perform physically demanding tasks. Employers may need to modify duties, offer flexible schedules, and/or support remote work to maintain productivity and safety.
Employees with hemophilia may need short, unplanned periods away from work to manage sudden bleeds. The U.S. Department of Labor’s FMLA Employer Guide provides a framework for implementing intermittent leave in small increments. When applied consistently, this approach keeps employees connected to the workforce and reduces the likelihood of extended disability leave.
Reasonable accommodations can help employees remain productive and safe. The Job Accommodation Network (JAN) Hemophilia Guide outlines practical options—such as flexible scheduling, reduced physical demands, and modified workspaces—that support employees while enabling them to perform essential job functions.
Employees caring for a child or family member with hemophilia often manage a significant “silent” workload, balancing treatment routines, medical appointments, and emotional stress. Resources such as Hope for Hemophilia and the Hemophilia Federation of America’s Mental Health Hub offer support programs that can reduce caregiver strain and help employees stay engaged at work.
Living with or caring for someone with hemophilia can contribute to anxiety, burnout, and financial stress. Employers that integrate mental health resources—EAP access, counseling, peer support, and condition specific education—can help employees navigate these challenges more effectively.
Hemophilia is rare, but its impact on cost, productivity, and employee well being is significant. Employers who understand the condition and implement proactive strategies—intermittent leave, ADA accommodations, caregiver support, and mental health resources—can reduce preventable disruptions, improve retention, and create a workplace environment that supports stability and long term success for employees and their families.
Because of the low prevalence of hemophilia, employers as a key payer group have very limited knowledge and receive minimal information from carriers, pharmacy benefit managers (PBMs), third-party administrators (TPAs), and pharmacy and medical consultants on best practices. Most often, employers receive information in a retrospective manner requiring them to respond after the condition presents in claims reports – leaving them without proactive strategies to manage care or spending.
The impact of complications, such as recurrent bleeding, affects the productivity of people with hemophilia and their caregivers, including:
- 26 missed days per year at work/school
- 20 low-productivity days per year
- 19 missed days per year for caregivers
- 19% of parents reported being underemployed due to their child's condition
Facts About Hemophilia
Clinically, people with hemophilia are lacking one or more important proteins called clotting factors. In the absence of these proteins, blood cannot clot normally. The specific type of hemophilia depends on which clotting factor is missing or deficient. People with hemophilia bleed longer than others after an injury or surgery and may also have internal bleeding that can damage organs and tissues and even be life-threatening. Women who inherit the hemophilia gene often have reduced clotting factor levels, which can lead to symptoms such as heavy periods, easy bruising, or bleeding into joints. In some cases, factor levels are low enough they meet the clinical criteria for a hemophilia diagnosis.
According to the National Bleeding Disorders Foundation (NCBD):
- Family history of hemophilia is present in almost two-thirds of cases
- Hemophilia occurs more commonly in males - 1 in every 5,617 male births
- Primary symptoms are bleeding longer than other people; bleeds can occur internally, into joints and muscles, or externally, from minor cuts, dental procedures, or injuries
- Bleeding can occur both externally and internally
- Internal bleeding, which often happens in the space around the joints (especially the knee, elbow, ankle) and in muscles, frequently causes pain and swelling and can lead to decreased mobility and disability
- Left untreated, bleeding can lead to permanent painful joint disease and sometimes death